Male Breast Cancer Completed Phase 1 / 2 Trials for Paclitaxel (DB01229)

IndicationStatusPhase
DBCOND0028546 (Male Breast Cancer)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00368875Phase I-II Study of Vorinostat, Paclitaxel, and Bevacizumab in Metastatic Breast CancerTreatment
NCT00470301Tipifarnib and Combination Chemotherapy in Treating Patients With Stage II or Stage III Breast CancerTreatment